Published in Biochem J on January 15, 2015
Induced pluripotent stem cells: at the heart of cardiovascular precision medicine. Nat Rev Cardiol (2016) 1.13
Differentiation of Human Induced-Pluripotent Stem Cells into Smooth-Muscle Cells: Two Novel Protocols. PLoS One (2016) 0.79
Vascular diseases await translation of blood vessels engineered from stem cells. Sci Transl Med (2015) 0.75
G-protein Coupled Receptor Signaling in Pluripotent Stem Cell-derived Cardiovascular Cells: Implications for Disease Modeling. Front Cell Dev Biol (2015) 0.75
Tissue-Engineered Vascular Rings from Human iPSC-Derived Smooth Muscle Cells. Stem Cell Reports (2016) 0.75
Stem cell-derived vasculature: A potent and multidimensional technology for basic research, disease modeling, and tissue engineering. Biochem Biophys Res Commun (2015) 0.75
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Induced pluripotent stem cell lines derived from human somatic cells. Science (2007) 71.50
Reprogramming of human somatic cells to pluripotency with defined factors. Nature (2007) 30.84
Human induced pluripotent stem cells free of vector and transgene sequences. Science (2009) 17.16
Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell (2010) 14.18
Molecular regulation of vessel maturation. Nat Med (2003) 11.74
Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell (2009) 11.65
piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature (2009) 11.27
Fate of the mammalian cardiac neural crest. Development (2000) 6.79
Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell (2011) 6.11
Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci (2009) 5.58
Building the mammalian heart from two sources of myocardial cells. Nat Rev Genet (2005) 5.51
Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet (2009) 5.16
Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science (2013) 4.94
A nonviral minicircle vector for deriving human iPS cells. Nat Methods (2010) 4.42
The arterial pole of the mouse heart forms from Fgf10-expressing cells in pharyngeal mesoderm. Dev Cell (2001) 4.27
Developmental basis of vascular smooth muscle diversity. Arterioscler Thromb Vasc Biol (2007) 4.09
Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell (2010) 4.03
Pericardial mesoderm generates a population of coronary smooth muscle cells migrating into the heart along with ingrowth of the epicardial organ. Dev Biol (1996) 3.70
A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell (2010) 3.41
Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg (2005) 2.83
Progress in understanding reprogramming to the induced pluripotent state. Nat Rev Genet (2011) 2.81
Induction of pluripotency in mouse somatic cells with lineage specifiers. Cell (2013) 2.69
Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector. Stem Cells (2010) 2.62
Neural crest cells retain multipotential characteristics in the developing valves and label the cardiac conduction system. Circ Res (2006) 2.59
Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. Proc Natl Acad Sci U S A (2011) 2.51
Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation (2003) 2.27
Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arterioscler Thromb Vasc Biol (2005) 2.20
Secondary heart field contributes myocardium and smooth muscle to the arterial pole of the developing heart. Dev Biol (2005) 2.15
Readily available tissue-engineered vascular grafts. Sci Transl Med (2011) 2.13
An essential role for Notch in neural crest during cardiovascular development and smooth muscle differentiation. J Clin Invest (2007) 2.09
The origin, formation and developmental significance of the epicardium: a review. Cells Tissues Organs (2001) 1.96
Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility. Nat Biotechnol (2012) 1.94
Steps toward safe cell therapy using induced pluripotent stem cells. Circ Res (2013) 1.80
BMP and FGF regulate the differentiation of multipotential pericardial mesoderm into the myocardial or epicardial lineage. Dev Biol (2006) 1.77
Requirement of myocardin-related transcription factor-B for remodeling of branchial arch arteries and smooth muscle differentiation. Proc Natl Acad Sci U S A (2005) 1.72
Epicardium-derived progenitor cells require beta-catenin for coronary artery formation. Proc Natl Acad Sci U S A (2007) 1.72
Myocardin-related transcription factor B is required in cardiac neural crest for smooth muscle differentiation and cardiovascular development. Proc Natl Acad Sci U S A (2005) 1.70
Modeling supravalvular aortic stenosis syndrome with human induced pluripotent stem cells. Circulation (2012) 1.69
Allogeneic human tissue-engineered blood vessel. J Vasc Surg (2011) 1.66
Functional vascular smooth muscle cells derived from human induced pluripotent stem cells via mesenchymal stem cell intermediates. Cardiovasc Res (2012) 1.65
Smooth muscle cells differentiated from reprogrammed embryonic lung fibroblasts through DKK3 signaling are potent for tissue engineering of vascular grafts. Circ Res (2013) 1.62
A role for serum response factor in coronary smooth muscle differentiation from proepicardial cells. Development (1999) 1.62
Developmental origin of smooth muscle cells in the descending aorta in mice. Development (2008) 1.59
Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature. Atherosclerosis (2009) 1.57
Wnt signaling and a Smad pathway blockade direct the differentiation of human pluripotent stem cells to multipotent neural crest cells. Proc Natl Acad Sci U S A (2011) 1.56
Smooth Muscle Lineage Diversity in the Chick Embryo Dev Biol (1996) 1.45
Hedgehog signaling to distinct cell types differentially regulates coronary artery and vein development. Development (2008) 1.40
Nkx2-5- and Isl1-expressing cardiac progenitors contribute to proepicardium. Biochem Biophys Res Commun (2008) 1.40
Posteriorization by FGF, Wnt, and retinoic acid is required for neural crest induction. Dev Biol (2002) 1.39
Notch and transforming growth factor-beta (TGFbeta) signaling pathways cooperatively regulate vascular smooth muscle cell differentiation. J Biol Chem (2010) 1.38
Coronary smooth muscle differentiation from proepicardial cells requires rhoA-mediated actin reorganization and p160 rho-kinase activity. Dev Biol (2001) 1.37
Functional recapitulation of smooth muscle cells via induced pluripotent stem cells from human aortic smooth muscle cells. Circ Res (2009) 1.34
Notch signaling regulates smooth muscle differentiation of epicardium-derived cells. Circ Res (2011) 1.34
Highly efficient induction and long-term maintenance of multipotent cardiovascular progenitors from human pluripotent stem cells under defined conditions. Cell Res (2013) 1.26
Inhibition of pluripotent stem cell-derived teratoma formation by small molecules. Proc Natl Acad Sci U S A (2013) 1.22
Angiotensin II induces a region-specific hyperplasia of the ascending aorta through regulation of inhibitor of differentiation 3. Circ Res (2009) 1.20
A highly efficient method to differentiate smooth muscle cells from human embryonic stem cells. Arterioscler Thromb Vasc Biol (2007) 1.20
Smooth muscle cell transplantation into myocardial scar tissue improves heart function. J Mol Cell Cardiol (1999) 1.19
Notch activation of Jagged1 contributes to the assembly of the arterial wall. Circulation (2011) 1.14
High-purity enrichment of functional cardiovascular cells from human iPS cells. Cardiovasc Res (2012) 1.07
Derivation and maturation of synthetic and contractile vascular smooth muscle cells from human pluripotent stem cells. Cardiovasc Res (2012) 1.05
Directed differentiation of human pluripotent cells to neural crest stem cells. Nat Protoc (2013) 1.04
A systematic evaluation of integration free reprogramming methods for deriving clinically relevant patient specific induced pluripotent stem (iPS) cells. PLoS One (2013) 1.03
Signaling during epicardium and coronary vessel development. Circ Res (2011) 1.02
Notch2 is required for the proliferation of cardiac neural crest-derived smooth muscle cells. Dev Dyn (2008) 0.96
Three-dimensional growth of iPS cell-derived smooth muscle cells on nanofibrous scaffolds. Biomaterials (2011) 0.96
Evaluation of the use of an induced puripotent stem cell sheet for the construction of tissue-engineered vascular grafts. J Thorac Cardiovasc Surg (2012) 0.96
Molecular regulation of smooth muscle cell differentiation. J Hypertens Suppl (1996) 0.94
Decreased levels of embryonic retinoic acid synthesis accelerate recovery from arterial growth delay in a mouse model of DiGeorge syndrome. Circ Res (2010) 0.94
Tumorigenicity studies for human pluripotent stem cell-derived products. Biol Pharm Bull (2013) 0.92
Tbx1 is regulated by forkhead proteins in the secondary heart field. Dev Dyn (2006) 0.92
Cell-based therapeutics from an economic perspective: primed for a commercial success or a research sinkhole? Regen Med (2008) 0.89
Notch pathway regulation of neural crest cell development in vivo. Dev Dyn (2012) 0.89
Vascular differentiation from embryonic stem cells: novel technologies and therapeutic promises. Vascul Pharmacol (2012) 0.88
Clinical therapy using iPSCs: hopes and challenges. Genomics Proteomics Bioinformatics (2013) 0.87
Embryonic origins of human vascular smooth muscle cells: implications for in vitro modeling and clinical application. Cell Mol Life Sci (2014) 0.82
Vascular smooth muscle cell phenotypic plasticity: focus on chromatin remodelling. Cardiovasc Res (2012) 0.82
Regenerative implants for cardiovascular tissue engineering. Transl Res (2014) 0.82
Clinical application of stem cells in the cardiovascular system. Adv Biochem Eng Biotechnol (2010) 0.81